Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002585812 | SCV002936447 | likely benign | not provided | 2022-09-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003375627 | SCV004062196 | uncertain significance | Inborn genetic diseases | 2023-07-25 | criteria provided, single submitter | clinical testing | The c.376T>G (p.F126V) alteration is located in exon 2 (coding exon 2) of the IFITM5 gene. This alteration results from a T to G substitution at nucleotide position 376, causing the phenylalanine (F) at amino acid position 126 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV002585812 | SCV005412257 | uncertain significance | not provided | 2023-11-15 | criteria provided, single submitter | clinical testing | PM2 |